Pages that link to "Template:DocumentData"

The following pages link to Template:DocumentData:

Displaying 50 items.

• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 49 (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 50 (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 53 (transclusion) (← links)
• Reference:DEU StrlSchG - Strahlenschutzgesetz 03-Jan-2022 § 32 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63f (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63g (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 67 (6) (transclusion) (← links)
• Reference:DEU SGB V - Sozialgesetzbuch Fünftes Buch 20-Dez-1988 § 35a (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.3 (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.3 (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Ende (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2 (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.7.5 (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 3.2 (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 3.3 (transclusion) (← links)
• Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20 (transclusion) (← links)
• Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20-1 (transclusion) (← links)
• Reference:FRA SI RIPH 2G - Website 16-May-2025 - (transclusion) (← links)
• Reference:FRA AEC-DM-DMDIV DOC006 v04 AAP RDM Partie II Modalités pratiques 16-May-2025 - (transclusion) (← links)
• Reference:FRA AEC DOC010 V.04 01-Jun-2018 - (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 (1) (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 14 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (1) - (6) (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (7) - (10) (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 16 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 17 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 18 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20 (transclusion) (← links)
• Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 16 (1) - (3) (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4. (transclusion) (← links)
• Reference:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 - (transclusion) (← links)
• Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 IRAS (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.102 (m) (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.103 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.104 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.105 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.109 (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.111 - §56.112 (transclusion) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.124 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.40 (b) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart B (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.30 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.42 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart D (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.4 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.6 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.8 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.24 (transclusion) (← links)